HCM
COLL icon

Highbridge Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Highbridge Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,741
Closed -$434K – 1556
2017
Q2 		$434K Sell
34,741
-14,387
-29% -$142K 0.01% 802
2017
Q1 		$494K Buy
+49,128
New +$730K 0.01% 911
2016
Q3 		– Sell
-13,951
Closed -$166K – 1360
2016
Q2 		$166K Buy
+13,951
New +$230K ﹤0.01% 1268

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Highbridge Capital Management's COLL Position: Q3 2017 in Review

Highbridge Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2017, closing a stake of 34,741 shares — an estimated $434K sold.

Highbridge Capital Management first reported a position in COLL in Q2 2016 and held it in 3 quarters. The position peaked at $494K in Q1 2017. 75 funds tracked by Wall St. Rank hold COLL as of Q3 2017.

  • Highbridge Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 34,741 Collegium Pharmaceutical shares in Q3 2017, an estimated $434K.
  • Highbridge Capital Management first reported a position in Collegium Pharmaceutical in Q2 2016 and held it in 3 quarters.
  • Highbridge Capital Management's Collegium Pharmaceutical position peaked at $494K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2017.

Based on Highbridge Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.